CUPR
Cuprina Holdings (Cayman) Limited
Price Chart
Latest Quote
$3.97
-0.04 (-1.00%)
Current Price
| Previous Close | $4.01 |
| Open | $3.87 |
| Day High | $4.04 |
| Day Low | $3.85 |
| Volume | 15,394 |
Stock Information
Note: Financial values converted from SGD to USD
| Shares Outstanding | 921K |
| Total Debt | $2.64M |
| Cash Equivalents | $2.48M |
| Revenue | $39K |
| Net Income | $-3.62M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $10.64M |
| EPS (TTM) | $-1.41 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $10.96M |
| Sales | $39K |
| Income | $-3.62M |
| Book/sh | $1.46 |
| Cash/sh | $3.48 |
| Employees | 10 |
Financial Ratios
| Quick Ratio | 1.03 |
| Current Ratio | 2.35 |
| Debt/Eq | 67.52 |
Returns & Margins
| ROA | -58.90% |
| ROE | -1569.06% |
| Gross Margin | -1.29% |
| Operating Margin | -10568.35% |
Ownership
| Institutional Ownership | 1.22% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 213.34 |
| P/B | 2.72 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $4.95 |
| SMA50 | $3.65 |
| SMA200 | $4.22 |
| RSI | 39.41 |
| ATR | 0.8672 |
| Shares Float | 921K |
| Short Float | 7.10% |
| Short Ratio | 0.01 |
| Rel Volume | 0.01 |
Performance History
| Week | -20.12% |
| Month | -24.67% |
| Quarter | +42.60% |
| 6 Months | +4.92% |
| YTD | +23.45% |
| Year | -93.38% |
| 10 Years | -88.04% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $3.97 | 15,394 |
| 2026-07-16 | $4.01 | 20,800 |
| 2026-07-15 | $4.21 | 14,300 |
| 2026-07-14 | $4.09 | 22,300 |
| 2026-07-13 | $4.33 | 33,000 |
| 2026-07-10 | $4.97 | 33,800 |
| 2026-07-09 | $5.29 | 41,600 |
| 2026-07-08 | $5.09 | 76,700 |
| 2026-07-07 | $5.74 | 69,600 |
| 2026-07-06 | $5.66 | 85,400 |
| 2026-07-02 | $5.77 | 201,100 |
| 2026-07-01 | $5.96 | 408,800 |
| 2026-06-30 | $6.59 | 26,248,300 |
| 2026-06-29 | $4.46 | 128,800 |
| 2026-06-26 | $5.33 | 103,400 |
| 2026-06-25 | $5.65 | 368,100 |
| 2026-06-24 | $5.74 | 25,833,400 |
| 2026-06-23 | $3.94 | 68,500 |
| 2026-06-22 | $3.93 | 150,500 |
| 2026-06-18 | $4.37 | 262,100 |
About Cuprina Holdings (Cayman) Limited
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
đ° Latest News
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires âĸ 2026-06-15T19:46:51ZTop Midday Gainers
MT Newswires âĸ 2026-06-15T18:00:47ZSector Update: Healthcare Stocks Softer Monday Afternoon
MT Newswires âĸ 2026-06-15T17:50:10ZWhy Did CUPR Stock Surge Over 150% Today?
Stocktwits âĸ 2026-06-15T17:40:14Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $31,451 | $31,720 | $43,567 | $26,938 |
| Cost Of Revenue | $39,247 | $39,872 | $49,830 | $28,438 |
| Total Revenue | $38,746 | $37,524 | $78,256 | $43,953 |
| Operating Revenue | $38,746 | $37,524 | $78,256 | $43,953 |
| Expenses | ||||
| Interest Expense | $11,434 | $28,896 | $43,943 | $1,566 |
| Total Expenses | $3,585,766 | $1,186,402 | $877,912 | $917,365 |
| Rent Expense Supplemental | $53,027 | $39,320 | $36,967 | $24,883 |
| Other Income Expense | $-42,192 | $6,251 | $435 | $30,725 |
| Other Non Operating Income Expenses | $54,219 | $7,780 | $2,379 | $37,613 |
| Net Non Operating Interest Income Expense | $9,193 | $-28,896 | $-43,943 | $-1,566 |
| Interest Expense Non Operating | $11,434 | $28,896 | $43,943 | $1,566 |
| Operating Expense | $3,546,519 | $1,146,529 | $828,081 | $888,926 |
| Other Operating Expenses | $-62,874 | $-56,172 | $6,650 | $-11,238 |
| Selling And Marketing Expense | $6,132 | $5,048 | $5,235 | $30,846 |
| General And Administrative Expense | $3,406,505 | $985,614 | $642,917 | $613,975 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,629,213 | $-1,211,850 | $-869,402 | $-849,958 |
| Net Interest Income | $9,193 | $-28,896 | $-43,943 | $-1,566 |
| Interest Income | $20,627 | - | - | - |
| Normalized Income | $-3,532,802 | $-1,210,320 | $-867,458 | $-843,070 |
| Net Income From Continuing And Discontinued Operation | $-3,629,213 | $-1,211,850 | $-869,402 | $-849,958 |
| Total Operating Income As Reported | $-3,750,653 | $-1,277,643 | $-829,622 | $-913,070 |
| Net Income Common Stockholders | $-3,629,213 | $-1,211,850 | $-869,402 | $-849,958 |
| Net Income | $-3,629,213 | $-1,211,850 | $-869,402 | $-849,958 |
| Net Income Including Noncontrolling Interests | $-3,629,213 | $-1,211,850 | $-869,402 | $-849,958 |
| Net Income Continuous Operations | $-3,629,213 | $-1,211,850 | $-869,402 | $-849,958 |
| Earnings From Equity Interest Net Of Tax | $-49,194 | $-40,328 | $-26,238 | $-5,704 |
| Pretax Income | $-3,580,019 | $-1,171,522 | $-843,164 | $-844,254 |
| Interest Income Non Operating | $20,627 | - | - | - |
| Operating Income | $-3,547,020 | $-1,148,877 | $-799,655 | $-873,412 |
| Depreciation Amortization Depletion Income Statement | $20,567 | $24,607 | $20,962 | $21,088 |
| Depreciation And Amortization In Income Statement | $20,567 | $24,607 | $20,962 | $21,088 |
| Gross Profit | $-501 | $-2,348 | $28,426 | $15,514 |
| Special Income Charges | - | $0 | $0 | $-6,888 |
| Per Share | ||||
| Diluted EPS | - | $-0.45 | $-0.32 | $-0.32 |
| Basic EPS | - | $-0.45 | $-0.32 | $-0.32 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,443,811 | $-1,108,338 | $-770,051 | $-813,211 |
| Total Unusual Items | $-96,412 | $-1,529 | $-1,944 | $-6,888 |
| Total Unusual Items Excluding Goodwill | $-96,412 | $-1,529 | $-1,944 | $-6,888 |
| Reconciled Depreciation | $28,362 | $32,759 | $27,225 | $22,589 |
| EBITDA (Bullshit earnings) | $-3,540,223 | $-1,109,867 | $-771,995 | $-820,099 |
| EBIT | $-3,568,585 | $-1,142,626 | $-799,220 | $-842,688 |
| Diluted NI Availto Com Stockholders | $-3,629,213 | $-1,211,850 | $-869,402 | $-849,958 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $-96,412 | $-1,529 | $-1,944 | - |
| Research And Development | $176,189 | $187,432 | $130,256 | $227,438 |
| Selling General And Administration | $3,412,637 | $990,663 | $648,152 | $644,821 |
| Other Gand A | $2,576,014 | $303,741 | $88,460 | $43,130 |
| Insurance And Claims | $38,150 | $8,264 | $6,986 | $1,736 |
| Rent And Landing Fees | $41,173 | $27,614 | $25,262 | $12,726 |
| Salaries And Wages | $751,168 | $645,994 | $522,210 | $556,382 |
| Diluted Average Shares | - | $2,111,273 | $2,111,273 | $2,038,471 |
| Basic Average Shares | - | $2,111,273 | $2,111,273 | $2,038,471 |
| Gain On Sale Of Ppe | - | $0 | $0 | $-6,888 |
| Provision For Doubtful Accounts | - | $0 | $22,061 | $6,817 |
Fetched: 2026-07-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,925,842 | $-3,463,243 | $-2,249,916 | $-1,380,956 |
| Total Assets | $6,604,332 | $1,355,125 | $1,231,392 | $1,115,235 |
| Total Non Current Assets | $911,234 | $69,118 | $116,990 | $129,663 |
| Non Current Prepaid Assets | $605,075 | $0 | - | - |
| Current Assets | $5,693,099 | $1,286,007 | $1,114,402 | $985,572 |
| Other Current Assets | $2,847 | - | $13,590 | $19,058 |
| Current Deferred Assets | $0 | $987,942 | $794,767 | $103,564 |
| Prepaid Assets | $3,070,423 | $113,496 | $108,168 | $77,755 |
| Inventory | $0 | $1,343 | $5,952 | $5,048 |
| Receivables | $198,761 | $92,779 | $164,541 | $341,719 |
| Accounts Receivable | $14,147 | $20,493 | $39,464 | $32,400 |
| Allowance For Doubtful Accounts Receivable | $-38,166 | $-38,166 | $-38,166 | $-16,104 |
| Gross Accounts Receivable | $52,313 | $58,658 | $77,630 | $48,504 |
| Cash Cash Equivalents And Short Term Investments | $2,421,068 | $90,448 | $27,384 | $438,427 |
| Cash And Cash Equivalents | $2,421,068 | $90,448 | $27,384 | $438,427 |
| Other Receivables | - | - | - | $1,932 |
| Debt | ||||
| Total Debt | $374,860 | $197,860 | $94,601 | $142,604 |
| Long Term Debt And Capital Lease Obligation | $259,183 | $127,145 | $44,662 | $95,448 |
| Long Term Debt | $98,003 | $127,145 | $16,851 | $33,527 |
| Current Debt And Capital Lease Obligation | $115,677 | $70,715 | $49,939 | $47,156 |
| Current Debt | $30,075 | $42,905 | $16,191 | $15,492 |
| Other Current Borrowings | $30,075 | $42,905 | $16,191 | $15,492 |
| Net Debt | - | $79,602 | $5,659 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,678,490 | $4,818,368 | $3,481,308 | $2,496,192 |
| Total Non Current Liabilities Net Minority Interest | $259,183 | $127,145 | $44,662 | $95,448 |
| Current Liabilities | $2,419,307 | $4,691,223 | $3,436,647 | $2,400,744 |
| Payables And Accrued Expenses | $2,303,630 | $4,620,508 | $3,386,708 | $2,353,588 |
| Payables | $2,286,093 | $4,620,444 | $3,386,484 | $2,353,525 |
| Other Payable | $6,247 | $251,519 | $291,327 | $138,954 |
| Accounts Payable | $914 | $0 | $0 | $0 |
| Equity | ||||
| Common Stock Equity | $3,925,842 | $-3,463,243 | $-2,249,916 | $-1,380,956 |
| Total Equity Gross Minority Interest | $3,925,842 | $-3,463,243 | $-2,249,916 | $-1,380,956 |
| Stockholders Equity | $3,925,842 | $-3,463,243 | $-2,249,916 | $-1,380,956 |
| Gains Losses Not Affecting Retained Earnings | $270,664 | $-1,238 | $240 | $-203 |
| Other Equity Adjustments | $270,664 | $-1,238 | $240 | $-203 |
| Retained Earnings | $-7,171,146 | $-3,541,933 | $-2,330,083 | $-1,460,681 |
| Long Term Equity Investment | $0 | $0 | $0 | $6,127 |
| Other | ||||
| Ordinary Shares Number | $2,082,152 | $2,111,273 | $2,111,273 | $2,111,273 |
| Share Issued | $2,082,152 | $2,111,273 | $2,111,273 | $2,111,273 |
| Tangible Book Value | $3,925,842 | $-3,463,243 | $-2,249,916 | $-1,380,956 |
| Invested Capital | $4,053,920 | $-3,293,193 | $-2,216,873 | $-1,331,937 |
| Working Capital | $3,273,792 | $-3,405,216 | $-2,322,245 | $-1,415,172 |
| Capital Lease Obligations | $246,783 | $27,810 | $61,558 | $93,584 |
| Total Capitalization | $4,023,845 | $-3,336,098 | $-2,233,064 | $-1,347,429 |
| Additional Paid In Capital | $10,804,111 | $61,132 | $61,132 | $61,132 |
| Capital Stock | $22,214 | $18,795 | $18,795 | $18,795 |
| Common Stock | $22,214 | $18,795 | $18,795 | $18,795 |
| Long Term Capital Lease Obligation | $161,181 | $0 | $27,810 | $61,921 |
| Current Capital Lease Obligation | $85,603 | $27,810 | $33,748 | $31,663 |
| Current Accrued Expenses | $17,536 | $64 | $224 | $63 |
| Dueto Related Parties Current | $2,278,933 | $4,368,925 | $3,095,157 | $2,214,571 |
| Investments And Advances | $0 | $0 | $0 | $6,127 |
| Net PPE | $306,159 | $69,118 | $116,990 | $123,536 |
| Accumulated Depreciation | $-144,221 | $-115,859 | $-83,100 | $-55,874 |
| Gross PPE | $450,380 | $184,977 | $200,090 | $179,410 |
| Other Properties | $109,571 | $74,626 | $74,626 | $56,478 |
| Machinery Furniture Equipment | $94,853 | $86,324 | $69,330 | $34,690 |
| Buildings And Improvements | $245,956 | $24,027 | $56,134 | $88,243 |
| Properties | $0 | $0 | $0 | $0 |
| Duefrom Related Parties Current | $184,613 | $72,286 | $125,077 | $307,387 |
| Investmentsin Joint Venturesat Cost | - | - | - | $6,127 |
Fetched: 2026-07-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-7,138,446 | $-976,831 | $-747,812 | $-1,448,880 |
| Operating Activities | ||||
| Operating Cash Flow | $-7,093,226 | $-959,836 | $-695,023 | $-1,436,417 |
| Cash Flow From Continuing Operating Activities | $-7,093,226 | $-959,836 | $-695,023 | $-1,436,417 |
| Operating Gains Losses | $158,858 | $38,976 | $28,168 | $13,305 |
| Investing Activities | ||||
| Capital Expenditure | $-45,219 | $-16,995 | $-52,789 | $-12,463 |
| Investing Cash Flow | $-45,219 | $-16,995 | $-52,789 | $-24,294 |
| Cash Flow From Continuing Investing Activities | $-45,219 | $-16,995 | $-52,789 | $-24,294 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $13,672,470 | $0 | $0 | - |
| Financing Cash Flow | $9,498,906 | $1,041,374 | $336,317 | $1,303,488 |
| Cash Flow From Continuing Financing Activities | $9,498,906 | $1,041,374 | $336,317 | $1,303,488 |
| Net Other Financing Charges | $-4,131,590 | $904,364 | $352,294 | $1,318,598 |
| Net Common Stock Issuance | $13,672,470 | $0 | $0 | - |
| Common Stock Issuance | $13,672,470 | $0 | $0 | - |
| Other | ||||
| Repayment Of Debt | $-41,973 | $-18,306 | $-15,977 | $-15,110 |
| Issuance Of Debt | $0 | $155,316 | $0 | $0 |
| Interest Paid Supplemental Data | $54,814 | $172 | $565 | $1,566 |
| End Cash Position | $2,421,124 | $90,450 | $27,384 | $438,438 |
| Beginning Cash Position | $90,450 | $27,384 | $438,438 | $595,863 |
| Effect Of Exchange Rate Changes | $-29,786 | $-1,478 | $443 | $-203 |
| Changes In Cash | $2,360,460 | $64,543 | $-411,496 | $-157,223 |
| Net Issuance Payments Of Debt | $-41,973 | $137,010 | $-15,977 | $-15,110 |
| Net Long Term Debt Issuance | $-41,973 | $137,010 | $-15,977 | $-15,110 |
| Long Term Debt Payments | $-41,973 | $-18,306 | $-15,977 | $-15,110 |
| Long Term Debt Issuance | $0 | $155,316 | $0 | $0 |
| Net PPE Purchase And Sale | $-45,219 | $-16,995 | $-52,789 | $-12,463 |
| Purchase Of PPE | $-45,219 | $-16,995 | $-52,789 | $-12,463 |
| Change In Working Capital | $-3,651,281 | $177,336 | $96,861 | $-626,873 |
| Change In Other Current Assets | $-3,461,365 | $8,262 | $-24,945 | $-80,218 |
| Change In Payables And Accrued Expense | $-226,894 | $95,956 | $-35,616 | $-207,406 |
| Change In Accrued Expense | $-225,980 | $95,956 | $-35,616 | $-207,235 |
| Change In Payable | $-914 | - | - | $-171 |
| Change In Account Payable | $-914 | $0 | $0 | $-171 |
| Change In Prepaid Assets | $30,648 | $54,147 | $185,525 | $-304,494 |
| Change In Inventory | $0 | $0 | $-904 | $-5,049 |
| Change In Receivables | $6,330 | $18,972 | $-27,198 | $-29,706 |
| Changes In Account Receivables | $6,330 | $18,972 | $-29,130 | $-29,855 |
| Other Non Cash Items | $-2,956 | $-1,640 | $82 | $-2,279 |
| Provisionand Write Offof Assets | $0 | $0 | $22,062 | $6,818 |
| Asset Impairment Charge | $3,088 | $4,609 | $0 | $0 |
| Depreciation Amortization Depletion | $28,363 | $32,760 | $27,226 | $22,589 |
| Depreciation And Amortization | $28,363 | $32,760 | $27,226 | $22,589 |
| Depreciation | $28,363 | $32,760 | $27,226 | $22,589 |
| Earnings Losses From Equity Investments | $49,195 | $40,328 | $26,239 | $5,704 |
| Net Foreign Currency Exchange Gain Loss | $109,663 | $-1,352 | $1,929 | $815 |
| Net Income From Continuing Operations | $-3,629,298 | $-1,211,878 | $-869,422 | $-849,977 |
| Net Business Purchase And Sale | - | $0 | $0 | $-11,831 |
| Purchase Of Business | - | $0 | $0 | $-11,831 |
| Gain Loss On Sale Of PPE | - | $0 | $0 | $6,786 |
| Income Tax Paid Supplemental Data | - | - | $0 | $0 |
Fetched: 2026-07-15